Affimed Price to Book Ratio 2014-2024 | AFMDQ
Historical price to book ratio values for Affimed (AFMDQ) over the last 10 years. The current price to book ratio for Affimed as of May 23, 2025 is 0.02.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Affimed Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
|
0.00 |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.009B |
|
Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V., is based in Heidelberg, Germany.
|
